Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWestpac Per.frn Regulatory News (60IP)

Share Price Information for Westpac Per.frn (60IP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 74.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Yest. Close: 74.50
60IP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Westpac Banking. - Publication of Suppl.Prospcts

Tue, 26th Mar 2019 14:16

RNS Number : 0662U
Westpac Banking Corporation
26 March 2019
 

Publication of Supplementary Prospectus by Westpac Banking Corporation

The following Supplementary Prospectus has been approved by the United Kingdom Listing Authority and is available for viewing:

Supplementary Prospectus dated 26 March 2019 (the "Supplementary Prospectus") to the Base Prospectus dated 8 November 2018 (the "Base Prospectus"), relating to the U.S.$70 billion Programme for the Issuance of Debt Instruments established by Westpac Banking Corporation.

To view the Supplementary Prospectus in full, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/0662U_1-2019-3-26.pdf

A copy of the Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at www.morningstar.co.uk/uk/NSM.  For further information, please contact:

Leisha White

Westpac Banking Corporation Camomile Court 23 Camomile Street

London EC3A 7LL

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Supplementary Prospectus and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed.  Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

This publication does not constitute an offer of the debt instruments (the "Debt Instruments") for sale in the United States, and is not for distribution in or into the United States.  The Debt Instruments have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or any relevant securities laws of any state of the United States, and may not be offered, sold or delivered in the United States or to, or for the account or benefit of, U.S. persons, as such terms are defined in Regulation S under the Securities Act, unless in a transaction exempt from registration under the Securities Act and any other securities law.  The Debt Instruments will only be offered and sold without registration under the Securities Act to (a) "qualified institutional buyers" as defined in Rule 144A under the Securities Act ("Rule 144A") in reliance upon the exemptions provided by Section 4(2) of, and Rule 144A under, the Securities Act; and (b) non-U.S. persons in offshore transactions in reliance upon Regulation S under the Securities Act.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PSPZQLFLKXFFBBL

Login to your account

Don't have an account? Click here to register.